Clinical Trial Update: Spironolactone for Reducing Proteinuria in Diabetic Nephropathy [NA]

View source ↗

Summary

A VA-sponsored clinical trial evaluating spironolactone to reduce proteinuria in diabetic nephropathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy

Drugs mentioned

• Spironolactone (spironolactone)

Snippet

Sponsor: US Department of Veterans Affairs | Conditions: Diabetic Nephropathy | NA | Status: COMPLETED